- Minaris Regenerative Medicine GmbH has implemented the latest version of Körber’s Werum PAS-X MES, a digital Manufacturing Execution System (MES), at its site in Ottobrunn, Germany.
- The new system allows for paperless documentation of batches, faster batch releases, and efficient availability of a wide range of process information for clients.
Minaris Regenerative Medicine GmbH, a contract development and manufacturing organization (CDMO) for cell and gene therapies, has taken a significant step towards digital transformation. The company has implemented the newest version of Werum PAS-X MES by Körber, a digital Manufacturing Execution System (MES), at its German site in Ottobrunn near Munich. This move marks a shift in its production management to digital processes.
The MES allows batches to be documented paperless, checked, and released within the shortest possible time. “Through the ‘review by exception’ concept, we offer our customers efficient processes and more agility in a cost-effective manner,” said Renate Sporrer, COO of Minaris. The digital production management system also enables Minaris to make a wide range of process information for clients efficiently and quickly available.
Körber’s latest version Werum PAS-X MES 3.3 covers all of Minaris’ requirements, which allowed Minaris to implement the software without any customization. By using the “Continuous Evolution Stream” support model, Minaris ensures that the MES system can be updated every six months. The company will regularly benefit from new features as soon as they are released.
The status of equipment can also be controlled electronically. Via an interface, PAS-X MES integrates the Enterprise Resource Planning (ERP) system into the production IT infrastructure. This implementation is expected to bring operational advantages such as faster batch releases, as well as time and cost savings. “Werum PAS-X MES is an important building block for our customers to shorten their time to market,” added Sporrer.
Overview of outsourcing trends 
